| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/19/2009 | US20090048281 Organic Compounds |
| 02/19/2009 | US20090048280 such as 2-Amino-3-(4-(2-amino-6-((R)-2,2,2-trifluoro-1-(3'-methoxybiphenyl-4-yl)ethoxy)pyrimidin-4-yl)phenyl)propanoic acid, used as tryptophan hydroxylase inhibitors |
| 02/19/2009 | US20090048279 Quinazoline analogs as receptor tyrosine kinase inhibitors |
| 02/19/2009 | US20090048278 Novel Quinazoline-2,4-Diamine Derivatives and Their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| 02/19/2009 | US20090048277 N-methylamide of 7-[6-(2,6-dichlorophenyl)-8-methyl-7-oxo-7,8-dihydropyrido[2,3-d]pyrimidin-2-ylamino]-2,3-dihydrobenzo[1,4]dioxin-2-carboxylic acid; antiproliferative agents; anticarcinogenic agents |
| 02/19/2009 | US20090048276 Inhibitors of Fatty Acid Synthase (Fas) |
| 02/19/2009 | US20090048275 Solid forms comprising 4-[9-(tetrahydro-furan-3-yl)-8-(2,4,6-trifluoro-phenylamino)-9h-purin-2-ylamino]-cyclohexan-1-ol, compositions thereof, and uses therewith |
| 02/19/2009 | US20090048274 PYRAZOLO[3,4-d]PYRIMIDINE DERIVATIVES |
| 02/19/2009 | US20090048273 Premature ovulation preventive agent |
| 02/19/2009 | US20090048272 Preparation of paliperidone |
| 02/19/2009 | US20090048271 Heterocyclic compounds and uses as anticancer agents |
| 02/19/2009 | US20090048270 Compounds, Methods And Devices for Inhibiting Neoproliferative Changes in Blood Vessel Walls |
| 02/19/2009 | US20090048269 Chemical compounds-821 |
| 02/19/2009 | US20090048268 Anti-histamine compositions and use thereof |
| 02/19/2009 | US20090048267 Medicaments for the treatment or prevention of fibrotic diseases |
| 02/19/2009 | US20090048266 Effects of Inhibitors of Fgfr3 on Gene Transcription |
| 02/19/2009 | US20090048265 Novel antitumor agents and methods of their use |
| 02/19/2009 | US20090048264 Piperazine amide derivatives |
| 02/19/2009 | US20090048263 neuroprotectants such as 4-biphenyl-3-yl-N-pyridin-3-ylpiperazine-1-carboxamide effective in prevention and treatment of cerebrovascular disorders such as necrosis, hemorrhages, injuries, as antidepressants and/or anxiolytic agents |
| 02/19/2009 | US20090048262 Combination of 10-propargyl-10-deazaaminopterin and erlotinib for the treatment of non-small cell lung cancer |
| 02/19/2009 | US20090048261 Pharmaceutical Composition for Treatment of Ocular Hypertension |
| 02/19/2009 | US20090048260 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells |
| 02/19/2009 | US20090048259 Phthalazine compounds, compositions and methods of use |
| 02/19/2009 | US20090048258 Amide Compound |
| 02/19/2009 | US20090048257 Compounds that modulate ppar activity, their preparation and use |
| 02/19/2009 | US20090048256 1-(2-chlorophenyl)-5-(4-chlorophenyl)-4-methoxy-3-[N-(1-azacycloheptyl)-carbamoyl]-1H-pyrazole, useful for treatment of nervous system disorders |
| 02/19/2009 | US20090048255 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 02/19/2009 | US20090048254 Salts and polymorphs of a vegf-r inhibitor |
| 02/19/2009 | US20090048253 Benzenoid ansamycin derivative |
| 02/19/2009 | US20090048252 Thiazolones for use as pi3 kinase inhibitors |
| 02/19/2009 | US20090048251 4-(1h-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer |
| 02/19/2009 | US20090048250 protein kinase inhibitors such as 6-[4-(5-Cyclopropyl-2H-pyrazol-3-ylamino)-quinazolin-2-ylamino]-1,2-dihydro-indazol-3-one, used for treating diabetes, infections, inflammatory, allergic, autoimmune, proliferative, viral and Alzheimer's diseases, or immunodeficiency, cardiovascular and bone disorders |
| 02/19/2009 | US20090048249 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| 02/19/2009 | US20090048248 Octahydropyrano[3,4-C]Pyrrole Tachykinin Receptor Antagonists |
| 02/19/2009 | US20090048247 Condensed isoxaline derivatives as inhibitors of phosphodiesterase type - iv |
| 02/19/2009 | US20090048246 Compounds, compositions and methods for reducing lipid levels |
| 02/19/2009 | US20090048245 Imidazolopyridine compounds useful for the treatment of degenerative and inflammatory diseases |
| 02/19/2009 | US20090048244 Pyrrolotriazine compounds as kinase inhibitors |
| 02/19/2009 | US20090048243 Therapeutic agent for attention-deficit hyperactivity disorder |
| 02/19/2009 | US20090048242 (1,10b-dihydro-2-(aminoalkyl-phenyl)-5h-pyrazolo[1,5 c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors |
| 02/19/2009 | US20090048241 such as 4-(5,6-Dihydro-8H-imidazo[5,1-c][1,4]oxazin-8-yl)benzonitrile, used for the treatment of estrogen-dependent breast cancer and urogenital disorders |
| 02/19/2009 | US20090048240 1,3-oxazinan-2-one compounds; antibiotic resistance |
| 02/19/2009 | US20090048239 Therapeutic compounds |
| 02/19/2009 | US20090048238 Novel biaryl derivatives |
| 02/19/2009 | US20090048237 Compositions and methods for procedural sedation and analgesia using oral transmucosal dosage forms |
| 02/19/2009 | US20090048236 New phenylalanine derivatives |
| 02/19/2009 | US20090048235 Substituted 5-vinylphenyl-1-phenyl-pyrazole cannabinoid modulators |
| 02/19/2009 | US20090048234 Pharmaceutical compositions and methods for preventing, treating, or reversing neuronal dysfunction |
| 02/19/2009 | US20090048233 Enhancing the Tolerability of a Seratonin Antagonist and a NSRI, a SNRI or a RIMA by Using Them in Combination |
| 02/19/2009 | US20090048232 Compositions and methods for prophylaxis and treatment of addictions |
| 02/19/2009 | US20090048231 Substituted prolinamides, the preparation thereof and the use thereof as pharmaceutical compositions |
| 02/19/2009 | US20090048230 Compounds and compositions useful as cathepsin s inhibitors |
| 02/19/2009 | US20090048229 Methods for promoting wakefulness |
| 02/19/2009 | US20090048228 Heterocycle Derivatives As Histone Deacetylase (Hdac) Inhibitors |
| 02/19/2009 | US20090048227 Substituted-1-Phthalazinamines As Vr- 1 Antagonists |
| 02/19/2009 | US20090048226 Inhibitors of caspases |
| 02/19/2009 | US20090048225 Histamine h3 receptor agents, preparation and therapeutic uses |
| 02/19/2009 | US20090048224 Compounds and methods of use |
| 02/19/2009 | US20090048223 Sulfonamide compound |
| 02/19/2009 | US20090048222 Triaza Compound Immunoregulatory Agents |
| 02/19/2009 | US20090048221 Conjugates with Anti-Inflammatory Activity |
| 02/19/2009 | US20090048220 Derivatives of 1-phenyl-2-pyridinyl alkyl alcohols as phosphodiesterase inhibitors |
| 02/19/2009 | US20090048219 Organic nitric oxide donor salts of nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/19/2009 | US20090048218 17Beta-CYANO-18A-HOMO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE |
| 02/19/2009 | US20090048217 17Beta-CYANO-19-NOR-ANDROST-4-ENE DERIVATIVE, ITS USE AND MEDICAMENTS COMPRISING THE DERIVATIVE |
| 02/19/2009 | US20090048216 Intravenous and oral dosing of a direct-acting and reversible p2y12 inhibitor |
| 02/19/2009 | US20090048215 Compositions for Ameliorating a Reduced Higher Brain Function Resulting From Organic Brain Lesions |
| 02/19/2009 | US20090048214 Methods for Treating Renal Tumors Using 2, 4-Pyrimidinediamine Drug and Prodrug Compounds |
| 02/19/2009 | US20090048213 Prodrug of cinnamide compound |
| 02/19/2009 | US20090048211 External preparation composition |
| 02/19/2009 | US20090048210 Agent for therapy or treatment of wound |
| 02/19/2009 | US20090048209 Compositions comprising dc-sign blockers and methods of using dc-sign blockers for preventing or treating diseases of a mammal, including viral infections |
| 02/19/2009 | US20090048208 Method for producing the low molecular weight beta-glucan by irradiation and low molecular weight beta-glucan produced by the method |
| 02/19/2009 | US20090048207 Hydrazide-containing cftr inhibitor compounds and uses thereof |
| 02/19/2009 | US20090048206 Edible powder meterial having excellent shelf stability |
| 02/19/2009 | US20090048205 Combination therapy with synthetic triterpenoids and gemcitabine |
| 02/19/2009 | US20090048204 Novel forms of cddo methyl ester |
| 02/19/2009 | US20090048203 Substituted adenines and the uses thereof |
| 02/19/2009 | US20090048202 Selective inhibitors of translesion dna replication |
| 02/19/2009 | US20090048201 Use of targeted cross-linked nanoparticles for in vivo gene delivery |
| 02/19/2009 | US20090048200 GPR 26 G-Protein Coupled Receptor |
| 02/19/2009 | US20090048199 Hibernation-Related Genes and Proteins, Activators and Inhibitors Thereof and Methods of Use |
| 02/19/2009 | US20090048198 Compositions and methods for nucleic acid delivery systems |
| 02/19/2009 | US20090048197 Lipid Nanoparticle Based Compositions and Methods for the Delivery of Biologically Active Molecules |
| 02/19/2009 | US20090048196 Membrane receptor for retinol binding protein mediates cellular uptake of vitamin A, methods of use and compositions |
| 02/19/2009 | US20090048195 Compositions and methods of sphingosine kinase inhibitors for use thereof in cancer therapy |
| 02/19/2009 | US20090048194 Vagal Afferent Neurons as Targets for Treatment |
| 02/19/2009 | US20090048193 Administration of the REG1 anticoagulation system |
| 02/19/2009 | US20090048192 Double Strand Compositions Comprising Differentially Modified Strands for Use in Gene Modulation |
| 02/19/2009 | US20090048191 Therapeutic molecules for modulating stability of vegf |
| 02/19/2009 | US20090048190 Antiviral activity and resolution of 2-hydroxymethyl-5(5-fluorocytosin-1-yl)-1,3-oxathiolane |
| 02/19/2009 | US20090048189 Tricyclic-nucleoside compounds for treating viral infections |
| 02/19/2009 | US20090048188 Ophthalmic medicine composition |
| 02/19/2009 | US20090048187 Chemopreventive, Anticancer and Anti-Inflammatory Effects of Pinoresinol-Rich Olives |
| 02/19/2009 | US20090048186 Monosaccharide Derivatives as Anti-Inflammatory and/or Anti-Cancer Agents |
| 02/19/2009 | US20090048185 Therapeutic Drug for Suppressing Functions of NKT Cells Containing Glycolipid Derivative as Active Ingredient |
| 02/19/2009 | US20090048184 Method for Producing a Drug Extract That Contains Hydroxystilbene |
| 02/19/2009 | US20090048179 Use of 5-phosphodiesterase inhibitors to enhance the permeability of the blood-brain barrier of abnormal brain tissue and the blood-tumor barrier |
| 02/19/2009 | US20090048178 Lps or lipid a binding agent and novel peptide |
| 02/19/2009 | US20090048177 Methods for the treatment of mood disorders |